Our ability to deliver on our promise to develop novel therapies with high clinical value begins with our experienced, passionate team. Leadiant Biosciences, Inc., is led by a team of experienced pharmaceutical executives who share a common purpose: helping people affected by rare diseases. The team’s collective knowledge and unrivaled expertise in orphan drug development guides our research, development, and delivery of crucial therapies to patients who need them most.
Giuseppe Izzi
Chief Executive Officer
Giuseppe Izzi is the Chief Executive Officer at Leadiant Biosciences, Inc. He has more than 20 years of financial experience and was previously the Vice President, Administration and Chief Financial Officer of Leadiant Biosciences, Inc. and the Financial Director for Sigma-Tau España based in Madrid, Spain.
Read More
Prior to joining Leadiant, Giuseppe was an executive director with a major accounting firm, providing consulting services in capital market transactions, acquisitions, and audit. He is an experienced business operations and management professional with a demonstrated history of working in the pharmaceuticals industry.
Giuseppe received his bachelor’s degree in economics from the Università degli Studi di Roma ‘La Sapienza’.
Read Less
Alexandrine Froger, Ph.D.
Director, Regulatory and Scientific Affairs
Alexandrine Froger, Ph.D., is the Director, Regulatory and Scientific Affairs at Leadiant Biosciences, Inc., and is responsible for regulatory compliance and development strategies for Leadiant’s marketed and investigational product portfolio. She was previously the regulatory lead for several successful technological transfers and product launches.
Read More
Dr. Froger has been in the biomedical fields for over 25 years with more than 10 years of experience in regulatory affairs. Her regulatory knowledge spans from early IND stage to post-market drug and biologic applications involving treatments for rare disease, small molecule to biologics, labeling, and promotional labeling. Her therapeutic experiences include cardiovascular, oncology, neurology, and immunology.
Dr. Froger received her Ph.D. from the University of Rennes I, France and conducted several postdoctoral studies in the US and New Zealand before transitioning to regulatory affairs in 2010. When she is not collaborating with her colleagues at Leadiant, Dr. Froger enjoys gardening, baking for her friends and family, and traveling.
Read Less
Ping Hu, MBA
Head of Administration and Finance
Ping Hu is the Head of Administration and Finance at Leadiant Biosciences, Inc., and is responsible for the company’s finance, human resources, information technology, and contract management. She joined the company in 2010. Prior to joining the company, Ping worked at PricewaterhouseCoopers within the tax practice.
Read More
Ping has 30 years of experience in finance and tax. This includes many years of experience working at the global headquarter of an industry-leading manufacturing company, coordinating the financial operations and reporting of its subsidiaries in China.
Ping has a bachelor’s degree in accounting from Shanghai University of Science and Technology, an MBA from the University of Baltimore, and a master’s degree in taxation from American University. Ping is also an active Certified Public Accountant in Maryland and Virginia.
Read Less
Vineeth Raja, MBA
Head of Product Portfolio Management, Manufacturing, and Distribution
Vineeth Raja is the Head of Product Portfolio Management, Manufacturing and Distribution at Leadiant Biosciences, Inc. In his current role, he is responsible for all aspects of product portfolio and lifecycle management. He also oversees the manufacturing, supply chain, and distribution functions.
Read More
Vineeth has more than 20 years of work experience in the pharmaceuticals and life sciences industry. Over the years, he has been involved in and managed various initiatives including product launches, mergers, acquisitions, divestitures, new business development, geographical business expansions, market analysis, and operational improvements. Prior to joining Leadiant, he worked at a major consulting firm that provided business consulting services to major corporations worldwide.
Vineeth has a master’s degree in engineering from the University of Maryland at College Park. He also has an MBA from R.H. Smith School of Business at University of Maryland.
Read Less
Giuseppe D. Testa
Vice President, Product Development
Giuseppe Testa is Vice President, Product Development at Leadiant Biosciences, Inc., and is responsible for strategic and operational oversight of the development of novel therapeutics in clinical research. He has more than 30 years of experience in research and clinical development including trial planning and implementation, as well as project management, staff recruiting, and training. His therapeutic experiences include cardiovascular, oncology, and neurology, as well as immunology.
Read More
Giuseppe first joined Leadiant Biosciences, Inc., in 1987, serving as the Clinical Research Associate for the International Clinical Trials Division in Research & Development in Italy. In 1997, he transferred to the U.S. and most recently served as the Vice President of Clinical Development. Prior to that, he held a variety of positions with increasing responsibility within the company.
Giuseppe holds a bachelor of arts degree from the Università degli Studi di Roma ‘La Sapienza.’
Read Less
